CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2003-11-11 | IVY ROBERT E Director | Sale | −4,100 | $5.55 | $23K | 1,700 |
| 2003-11-11 | IVY ROBERT E Director | Option exercise · Non-Qualified Stock Option (Right to Buy) | −4,100 | 0 | ||
| 2003-11-10 | IVY ROBERT E Director | Option exercise | +5,900 | $0.63 | $4K | 7,600 |
| 2003-11-10 | IVY ROBERT E Director | Sale | −5,900 | $5.61 | $33K | 1,700 |
| 2003-11-10 | IVY ROBERT E Director | Option exercise · Non-Qualified Stock Option (Right to Buy) | −5,900 | 0 |
Page 46 of 46 · 905 trades